Youwen He

13PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical roboticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 21, 2026
Dalpiciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial.

|Apr 26, 2026
Multicenter Real-World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics.

|Feb 27, 2026
Immunotherapy and the Sequence Relative to Survival Outcomes in SCLC: Analysis of the National Cancer Database.

Dan Yao, Yinting Liu, Wenyao Yu

|Apr 14, 2025
Vps34 puts the 'e' in eTreg cells.

Ruchi Saxena, You-Wen He

|Jan 03, 2025
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

Jeffrey M Clarke, George R Simon, Hirva Mamdani

|Sep 03, 2024
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study.

Zhiyong Zeng, Apeng Yang, Jingke Yang

Pageof 3

Frequent Collaborators

4 joint publications

Ruchi Saxena

3 joint publications

Michael J Campa

3 joint publications

Elizabeth B Gottlin

3 joint publications

Edward F Patz